Méhtestrák: vizsgálatok itt: Norvégia
12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
- Where
- Oslo, Stavanger
- Életkor
- 18 év and over
- People
- 480 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06340568 · EU 2023-507525-42-00 - 3. fázisTaking peopleA Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Where
- Oslo, Stavanger, Tromsoe
- Életkor
- 18 év and over
- People
- 1123 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06952504 · EU 2024-519331-42-00 - 3. fázisTaking peopleStudy to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- Where
- Bergen, Oslo
- Életkor
- 18 év and over
- People
- 660 worldwide
- Run by
- Genmab
See details and how to joinNCT07166094 - 1/2. fázisTaking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Lørenskog, Oslo
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 2. fázisTaking peopleAdjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 393 worldwide
- Run by
- Canadian Cancer Trials Group
See details and how to joinNCT05640999 - 3. fázisTaking peopleDESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Where
- Oslo, Stavanger
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06989112 · EU 2023-508056-19-00 - 3. fázisTaking peopleStudy to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( RAINFOL-03 )
- Where
- Bergen, Oslo
- Életkor
- 18 év and over
- People
- 290 worldwide
- Run by
- Genmab A/S
See details and how to join2024-519818-31-01 · EU 2024-519818-31-01 - No phaseTaking peopleObservational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 1715 worldwide
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04291612 - 2/3. fázisTaking peopleStudy of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
- Where
- Kristiansand, Oslo, Tromsø
- Életkor
- 18 év and over
- People
- 268 worldwide
- Run by
- Kartos Therapeutics, Inc.
See details and how to joinNCT05797831 - No phaseTaking peopleLaparoscopic Robot-assisted Pelvic Exenteration for Pelvic Primary and Recurrent Cancers
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 40
- Run by
- Oslo University Hospital
See details and how to joinNCT05186493 - 4. fázisTaking peopleBiomarker Guided Treatment in Gynaecological Cancer
- Where
- Ålesund, Bergen, Førde, Kristiansand, Oslo, Stavanger, Trondheim
- Életkor
- 18 év to 95 év
- People
- 1300 worldwide
- Run by
- Haukeland University Hospital
See details and how to joinNCT02543710